Napromex

Napromex may be available in the countries listed below.

Ingredient matches for Napromex

Naproxen

Naproxen is reported as an ingredient of Napromex in the following countries:

• Finland

International Drug Name Search

Cebion Infantil / Masticable

Cebion Infantil/Masticable may be available in the countries listed below.

Ingredient matches for Cebion Infantil/Masticable

Ascorbic Acid

Ascorbic Acid is reported as an ingredient of Cebion Infantil/Masticable in the following countries:

• Chile

International Drug Name Search

Mesalazine PCH

Mesalazine PCH may be available in the countries listed below.

Ingredient matches for Mesalazine PCH

Mesalazine

Mesalazine is reported as an ingredient of Mesalazine PCH in the following countries:

• Netherlands

International Drug Name Search

Monizol

Monizol may be available in the countries listed below.

Ingredient matches for Monizol

Isosorbide Mononitrate

Isosorbide Mononitrate is reported as an ingredient of Monizol in the following countries:

• Serbia

Miconazole

Miconazole nitrate (a derivative of Miconazole) is reported as an ingredient of Monizol in the following countries:

• Argentina

International Drug Name Search

OM

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for OM

Oleandomycin

Oleandomycin is reported as an ingredient of OM in the following countries:

• United States

Omeprazole

Omeprazole is reported as an ingredient of OM in the following countries:

• Germany

International Drug Name Search

Nicardal

Nicardal may be available in the countries listed below.

Ingredient matches for Nicardal

Nicardipine

Nicardipine hydrochloride (a derivative of Nicardipine) is reported as an ingredient of Nicardal in the following countries:

• Italy

International Drug Name Search

Penlac

Penlac is a brand name of ciclopirox topical, approved by the FDA in the following formulation(s):

PENLAC (ciclopirox - solution; topical)

• 
  Manufacturer: SANOFI AVENTIS US
  
  Approval date: December 17, 1999
  
  Strength(s): 8% ^[RLD][AT]

Has a generic version of Penlac been approved?

Yes. The following products are equivalent to Penlac:

ciclopirox solution; topical

• 
  Manufacturer: ACTAVIS MID ATLANTIC
  
  Approval date: September 18, 2007
  
  Strength(s): 8% ^[AT]


• 
  Manufacturer: APOTEX CORP
  
  Approval date: September 18, 2007
  
  Strength(s): 8% ^[AT]


• 
  Manufacturer: G AND W LABS
  
  Approval date: September 18, 2007
  
  Strength(s): 8% ^[AT]


• 
  Manufacturer: HI TECH PHARMA
  
  Approval date: September 18, 2007
  
  Strength(s): 8% ^[AT]


• 
  Manufacturer: PERRIGO NEW YORK
  
  Approval date: September 18, 2007
  
  Strength(s): 8% ^[AT]


• 
  Manufacturer: SYNERX PHARMA
  
  Approval date: September 18, 2007
  
  Strength(s): 8% ^[AT]


• 
  Manufacturer: TARO PHARM INDS
  
  Approval date: September 18, 2007
  
  Strength(s): 8% ^[AT]


• 
  Manufacturer: TEVA PHARMS
  
  Approval date: September 18, 2007
  
  Strength(s): 8% ^[AT]


• 
  Manufacturer: TOLMAR
  
  Approval date: September 18, 2007
  
  Strength(s): 8% ^[AT]


• 
  Manufacturer: VERSAPHARM
  
  Approval date: February 17, 2010
  
  Strength(s): 8% ^[AT]


• 
  Manufacturer: WATSON LABS
  
  Approval date: September 18, 2007
  
  Strength(s): 8% ^[AT]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Penlac. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Penlac.

See also...

• Penlac Consumer Information (Drugs.com)
• Penlac Solution Consumer Information (Wolters Kluwer)
• Penlac Topical Advanced Consumer Information (Micromedex)
• Ciclopirox Cream Consumer Information (Wolters Kluwer)
• Ciclopirox Gel Consumer Information (Wolters Kluwer)
• Ciclopirox Shampoo Consumer Information (Wolters Kluwer)
• Ciclopirox Solution Consumer Information (Wolters Kluwer)
• Ciclopirox Solution Kit Consumer Information (Wolters Kluwer)
• Ciclopirox Suspension Consumer Information (Wolters Kluwer)
• Ciclopirox topical Consumer Information (Cerner Multum)
• Ciclopirox Topical Advanced Consumer Information (Micromedex)
• Ciclopirox Olamine AHFS DI Monographs (ASHP)

Nifedipine CF

Nifedipine CF may be available in the countries listed below.

Ingredient matches for Nifedipine CF

Nifedipine

Nifedipine is reported as an ingredient of Nifedipine CF in the following countries:

• Netherlands

International Drug Name Search

Carbenicillin

In the US, Carbenicillin (carbenicillin systemic) is a member of the drug class antipseudomonal penicillins and is used to treat Bladder Infection and Prostatitis.

US matches:

• Carbenicillin Indanyl


• Carbenicillin


• Carbenicillin Indanyl Sodium

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J01CA03

CAS registry number (Chemical Abstracts Service)

0004697-36-3

Chemical Formula

C17-H18-N2-O6-S

Molecular Weight

378

Therapeutic Category

Antibacterial: Penicillin, broad-spectrum

Chemical Name

4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[(carboxyphenylacetyl)amino]-3,3-dimethyl-7-oxo-, [2S-(2α,5α,6ß)]-

Foreign Names

• Carbenicillinum (Latin)
• Carbenicillin (German)
• Carbénicilline (French)
• Carbenicilina (Spanish)

Generic Names

• Carbenicillin (OS: BAN)
• Carbenicillina (OS: DCIT)
• Carbénicilline (OS: DCF)
• (α-Carboxybenzyl)penicillin (IS: WHO)
• BRL 2064 (IS: Beecham)
• CP 15639-2 (IS: Pfizer)
• NSC 111071 (IS)
• Carbenicillin Disodium (OS: USAN)
• Carbenicillin Sodium (OS: BANM)
• Carbenicillin Disodium (PH: USP 32)
• Carbenicillin Sodium (PH: JP VIII, Ph. Eur. 4)
• Carbenicillin-Dinatrium (PH: Ph. Eur. 4)
• Carbénicilline sodique (PH: Ph. Eur. 4)
• Carbenicillinum natricum (PH: Ph. Eur. 4)

Brand Names

• Carbenicilinã
  Antibiotice, Romania



• Carbenicillin
  Polfa Tarchomin, Poland



• Pyopen
  GlaxoSmithKline, United Arab Emirates; GlaxoSmithKline, Bahrain; GlaxoSmithKline, Ethiopia; GlaxoSmithKline, Iran; GlaxoSmithKline, Kuwait; GlaxoSmithKline, Qatar

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Noropen

Noropen may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Noropen

Benzylpenicillin

Benzylpenicillin monohydrate (a derivative of Benzylpenicillin) is reported as an ingredient of Noropen in the following countries:

• Norway

International Drug Name Search

Simator

Simator may be available in the countries listed below.

Ingredient matches for Simator

Simvastatin

Simvastatin is reported as an ingredient of Simator in the following countries:

• Ireland

International Drug Name Search

CO Clonazepam

CO Clonazepam may be available in the countries listed below.

Ingredient matches for CO Clonazepam

Clonazepam

Clonazepam is reported as an ingredient of CO Clonazepam in the following countries:

• Canada

International Drug Name Search

Paxil CR

See also: Generic Paxil

Paxil CR is a brand name of paroxetine, approved by the FDA in the following formulation(s):

PAXIL CR (paroxetine hydrochloride - tablet, extended release; oral)

• 
  Manufacturer: GLAXOSMITHKLINE
  
  Approval date: February 16, 1999
  
  Strength(s): EQ 12.5MG BASE ^[AB], EQ 25MG BASE ^[AB]


• 
  Manufacturer: GLAXOSMITHKLINE
  
  Approval date: December 6, 2000
  
  Strength(s): EQ 37.5MG BASE ^[RLD][AB]

Has a generic version of Paxil CR been approved?

A generic version of Paxil CR has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Paxil CR and have been approved by the FDA:

paroxetine hydrochloride tablet, extended release; oral

• 
  Manufacturer: MYLAN
  
  Approval date: June 29, 2007
  
  Strength(s): EQ 12.5MG BASE ^[AB], EQ 25MG BASE ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: April 14, 2011
  
  Strength(s): EQ 37.5MG BASE ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Paxil CR. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Tablets with controlled-rate release of active substances
  Patent 5,422,123
  Issued: June 6, 1995
  Inventor(s): Conte; Ubaldo & La Manna; Aldo & Colombo; Paolo
  Assignee(s): Jagotec AG
  Tablets with zero order controlled-rate of release of the active substances, consisting of a core of defined geometrical form containing the active substance, polymer substances which swell on contact with aqueous liquids and polymer substances with gelling properties, and a support applied to said core to partly cover its surface, the support consisting of polymer substances which are slowly soluble and/or slowly gellable in aqueous liquids, plasticizing substances, and possibly substances with an adjuvant function.
  
  Patent expiration dates:
  
  
  • June 6, 2012
    
  
  
  
  • December 6, 2012
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Form of paroxetine hydrochloride anhydrate
  Patent 5,872,132
  Issued: February 16, 1999
  Inventor(s): Ward; Neal & Jacewicz; Victor Witold
  Assignee(s): SmithKline Beecham Corporation
  "Paroxetine hydrochloride (I) anhydrate ##STR1## free of bound propan-2-ol, and various forms thereof, are useful in the treatment of depression and other disorders for which administration of selective serotonin reuptake inhibitors are indicated."
  
  Patent expiration dates:
  
  
  • May 19, 2015
    
  
  
  
  • November 19, 2015
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Form of paroxetine hydrochloride anhydrate
  Patent 5,900,423
  Issued: May 4, 1999
  Inventor(s): Ward; Neal & Jacewicz; Victor Witold
  Assignee(s): SmithKline Beecham Corporation
  "Paroxetine hydrochloride (I) anhydrate ##STR1## free of bound propan-2-ol, and various forms thereof, are useful in the treatment of depression and other disorders for which administration of selective serotonin reuptake inhibitors are indicated."
  
  Patent expiration dates:
  
  
  • May 19, 2015
    
  
  
  
  • November 19, 2015
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Paroxetine in the treatment of depression associated with withdrawal from heroin abuse and post-traumatic stress disorder
  Patent 6,121,291
  Issued: September 19, 2000
  Inventor(s): Gleason; Maurice
  Assignee(s): SmithKline Beecham plc
  This invention relates to the use of paroxetine or a pharmaceutically acceptable salt thereof for the treatment of post-traumatic stress disorder and depression associated with withdrawal from heroin abuse.
  
  Patent expiration dates:
  
  
  • March 17, 2017
    
    ✓ 
    Patent use: DEPRESSION
  
  
  
  • September 17, 2017
    
    ✓ 
    Patent use: DEPRESSION
    ✓ 
    Pediatric exclusivity
  
  



• 
  Paroxetine hydrochloride form A or C
  Patent 6,133,289
  Issued: October 17, 2000
  Inventor(s): Ward; Neal & Jacewicz; Victor Witold
  Assignee(s): SmithKline Beecham Corporation
  Invented are methods of treatment using novel forms of paroxetine hydrochloride anhydrate.
  
  Patent expiration dates:
  
  
  • May 19, 2015
    
    ✓ 
    Patent use: DEPRESSION
  
  
  
  • November 19, 2015
    
    ✓ 
    Patent use: DEPRESSION
    ✓ 
    Pediatric exclusivity
  
  



• 
  Controlled release compositions
  Patent 6,548,084
  Issued: April 15, 2003
  Inventor(s): Graham Stanley; Leonard & David Philip; Elder
  Assignee(s): SmithKline Beecham plc
  A controlled release or delayed release formulation contains a selective serotonin reuptake inhibitor (SSRI) such as paroxetine.
  
  Patent expiration dates:
  
  
  • July 19, 2016
    
  
  
  
  • January 19, 2017
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Paroxetine controlled release compositions
  Patent 7,229,640
  Issued: June 12, 2007
  Inventor(s): Leonard; Graham Stanley & Elder; David Philip
  Assignee(s): SmithKline Beecham p.l.c.
  A controlled release or delayed release formulation contains a selective serotonin reuptake inhibitor (SSRI) such as paroxtine.
  
  Patent expiration dates:
  
  
  • July 19, 2016
    
    ✓ 
    Patent use: DEPRESSION, PANIC DISORDER, PREMENSTRUAL DISORDERS AND SOCIAL ANXIETY DISORDER
    ✓ 
    Drug product
  
  

See also...

• Paxil CR Controlled-Release Tablets Consumer Information (Wolters Kluwer)
• Paxil CR Consumer Information (Cerner Multum)
• Paxil CR Advanced Consumer Information (Micromedex)
• Paroxetine Consumer Information (Drugs.com)
• Paroxetine Consumer Information (Wolters Kluwer)
• Paroxetine Controlled-Release Tablets Consumer Information (Wolters Kluwer)
• Paroxetine Mesylate Consumer Information (Wolters Kluwer)
• Paroxetine Suspension Consumer Information (Wolters Kluwer)
• Paroxetine Consumer Information (Cerner Multum)
• Paroxetine Advanced Consumer Information (Micromedex)
• Paroxetine Hydrochloride AHFS DI Monographs (ASHP)

Locoid C

Locoid C may be available in the countries listed below.

Ingredient matches for Locoid C

Chlorquinaldol

Chlorquinaldol is reported as an ingredient of Locoid C in the following countries:

• New Zealand

Hydrocortisone

Hydrocortisone 17α-butyrate (a derivative of Hydrocortisone) is reported as an ingredient of Locoid C in the following countries:

• New Zealand

International Drug Name Search

Amicin

Amicin may be available in the countries listed below.

Ingredient matches for Amicin

Amikacin

Amikacin sulfate (a derivative of Amikacin) is reported as an ingredient of Amicin in the following countries:

• India

International Drug Name Search

Peroxyderm

Peroxyderm may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Peroxyderm

Benzoyl Peroxide

Benzoyl Peroxide is reported as an ingredient of Peroxyderm in the following countries:

• Austria


• Germany


• Netherlands


• Switzerland

International Drug Name Search

Tamsulosin Hydrochloride Kiron

Tamsulosin Hydrochloride Kiron may be available in the countries listed below.

Ingredient matches for Tamsulosin Hydrochloride Kiron

Tamsulosin

Tamsulosin hydrochloride (a derivative of Tamsulosin) is reported as an ingredient of Tamsulosin Hydrochloride Kiron in the following countries:

• Latvia

International Drug Name Search

Flutonin 10 / 20

Flutonin 10/20 may be available in the countries listed below.

Ingredient matches for Flutonin 10/20

Fluoxetine

Fluoxetine is reported as an ingredient of Flutonin 10/20 in the following countries:

• Vietnam

International Drug Name Search

Busulfex

Busulfex is a brand name of busulfan, approved by the FDA in the following formulation(s):

BUSULFEX (busulfan - injectable; injection)

• 
  Manufacturer: OTSUKA PHARM
  
  Approval date: February 4, 1999
  
  Strength(s): 6MG/ML ^[RLD]

Has a generic version of Busulfex been approved?

No. There is currently no therapeutically equivalent version of Busulfex available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Busulfex. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Parenteral busulfan for treatment of malignant disease
  Patent 5,430,057
  Issued: July 4, 1995
  Inventor(s): Andersson; Borje S. & Bhagwatwar; Harshal P. & Chow; Diana S. L.
  Assignee(s): Board of Regents, The University of Texas System
  University of Houston-University Park
  Stable parenteral formulations of busulfan safe for parenteral administration are disclosed that exhibit improved bioavailability and optimize high dose busulfan therapy against malignant disease.
  
  Patent expiration dates:
  
  
  • September 30, 2013
    
    ✓ 
    Patent use: METHOD OF TREATING A MALIGNANT CONDITION THROUGH INTRAVASCULAR ADMINISTRATION OF BUSULFAN. METHOD FOR TREATING LEUKEMIA OR LYMPHOMA IN A PATIENT UNDERGOING A BONE MARROW TRANSPLANT THROUGH INTRAVENOUS ADMINISTRATION OF BUSULFAN
  
  
  
  • March 30, 2014
    
    ✓ 
    Patent use: METHOD OF TREATING A MALIGNANT CONDITION THROUGH INTRAVASCULAR ADMINISTRATION OF BUSULFAN. METHOD FOR TREATING LEUKEMIA OR LYMPHOMA IN A PATIENT UNDERGOING A BONE MARROW TRANSPLANT THROUGH INTRAVENOUS ADMINISTRATION OF BUSULFAN
    ✓ 
    Pediatric exclusivity
  
  



• 
  Parenteral busulfan for treatment of malignant disease
  Patent 5,559,148
  Issued: September 24, 1996
  Inventor(s): Andersson; Borje S. & Bhagwatwar; Harshal P. & Chow; Diana S.
  Assignee(s): Board of Regents, The University of Texas System
  University of Houston-University Park
  Stable parenteral formulations of busulfan for parenteral administration are disclosed. The improved bioavailability of the parenteral formulations optimizes high dose busulfan therapy against malignant disease and improves the safety of such therapy.
  
  Patent expiration dates:
  
  
  • September 30, 2013
    
    ✓ 
    Patent use: METHOD OF TREATING A MALIGNANT DISEASE THROUGH PARENTERAL ADMINISTRATION OF BUSULFAN. METHOD FOR TREATING A PATIENT UNDERGOING A BONE MARROW TRANSPLANT THROUGH INTRAVASCULAR ADMINISTRATION OF BUSULFAN
  
  
  
  • March 30, 2014
    
    ✓ 
    Patent use: METHOD OF TREATING A MALIGNANT DISEASE THROUGH PARENTERAL ADMINISTRATION OF BUSULFAN. METHOD FOR TREATING A PATIENT UNDERGOING A BONE MARROW TRANSPLANT THROUGH INTRAVASCULAR ADMINISTRATION OF BUSULFAN
    ✓ 
    Pediatric exclusivity
  
  

See also...

• Busulfex Consumer Information (Wolters Kluwer)
• Busulfex Consumer Information (Cerner Multum)
• Busulfex Advanced Consumer Information (Micromedex)
• Busulfan Consumer Information (Wolters Kluwer)
• Busulfan Tablet Consumer Information (Wolters Kluwer)
• Busulfan Consumer Information (Cerner Multum)
• Busulfan Intravenous Advanced Consumer Information (Micromedex)
• Busulfan AHFS DI Monographs (ASHP)

MabThera

Mabthera may be available in the countries listed below.

UK matches:

• Mabthera 100mg and 500mg concentrate for solution for infusion (SPC)

Ingredient matches for Mabthera

Rituximab

Rituximab is reported as an ingredient of Mabthera in the following countries:

• Albania


• Argentina


• Aruba


• Australia


• Austria


• Bahrain


• Bangladesh


• Belarus


• Belgium


• Bosnia & Herzegowina


• Brazil


• Chile


• China


• Colombia


• Croatia (Hrvatska)


• Cuba


• Cyprus


• Czech Republic


• Denmark


• Dominican Republic


• Ecuador


• Egypt


• Estonia


• Finland


• France


• Georgia


• Germany


• Greece


• Hong Kong


• Hungary


• Iceland


• India


• Indonesia


• Iran


• Iraq


• Ireland


• Israel


• Italy


• Jamaica


• Japan


• Jordan


• Kazakhstan


• Kuwait


• Lebanon


• Lithuania


• Luxembourg


• Macedonia


• Malaysia


• Mexico


• Morocco


• Nepal


• Netherlands


• New Zealand


• Norway


• Oman


• Pakistan


• Philippines


• Poland


• Portugal


• Qatar


• Romania


• Russian Federation


• Saudi Arabia


• Serbia


• Singapore


• Slovakia


• Slovenia


• South Africa


• Sri Lanka


• Sweden


• Switzerland


• Syria


• Taiwan


• Thailand


• Trinidad & Tobago


• Tunisia


• Turkey


• Ukraine


• United Arab Emirates


• United Kingdom


• Uruguay


• Venezuela


• Yemen

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Helmicide

Helmicide may be available in the countries listed below.

Ingredient matches for Helmicide

Piperazine

Piperazine hexahydrate (a derivative of Piperazine) is reported as an ingredient of Helmicide in the following countries:

• Turkey

International Drug Name Search

Pentoxifilina Alter

Pentoxifilina Alter may be available in the countries listed below.

Ingredient matches for Pentoxifilina Alter

Pentoxifylline

Pentoxifylline is reported as an ingredient of Pentoxifilina Alter in the following countries:

• Spain

International Drug Name Search

Lansobene

Lansobene may be available in the countries listed below.

Ingredient matches for Lansobene

Lansoprazole

Lansoprazole is reported as an ingredient of Lansobene in the following countries:

• Austria

International Drug Name Search

Estradiol Ratiopharm

Estradiol Ratiopharm may be available in the countries listed below.

Ingredient matches for Estradiol Ratiopharm

Estradiol

Estradiol hemihydrate (a derivative of Estradiol) is reported as an ingredient of Estradiol Ratiopharm in the following countries:

• Netherlands

International Drug Name Search

Pisacilina

Pisacilina may be available in the countries listed below.

Ingredient matches for Pisacilina

Benzylpenicillin

Benzylpenicillin benzathine (a derivative of Benzylpenicillin) is reported as an ingredient of Pisacilina in the following countries:

• Peru

International Drug Name Search

Sonazine

Ingredient matches for Sonazine

Chlorpromazine

Chlorpromazine hydrochloride (a derivative of Chlorpromazine) is reported as an ingredient of Sonazine in the following countries:

• United States

International Drug Name Search

Lamotrigina Bexal

Lamotrigina Bexal may be available in the countries listed below.

Ingredient matches for Lamotrigina Bexal

Lamotrigine

Lamotrigine is reported as an ingredient of Lamotrigina Bexal in the following countries:

• Spain

International Drug Name Search

Diflex

Diflex may be available in the countries listed below.

Ingredient matches for Diflex

Diclofenac

Diclofenac is reported as an ingredient of Diflex in the following countries:

• Dominican Republic

Diclofenac potassium salt (a derivative of Diclofenac) is reported as an ingredient of Diflex in the following countries:

• Dominican Republic

International Drug Name Search

Roximin-Galenica

Roximin-Galenica may be available in the countries listed below.

Ingredient matches for Roximin-Galenica

Roxithromycin

Roxithromycin is reported as an ingredient of Roximin-Galenica in the following countries:

• Greece

International Drug Name Search

Black Widow Spider (Latrodectus Mactans) Antivenin

Pronunciation: Not applicable.
Generic Name: Black Widow Spider (Latrodectus Mactans) Antivenin
Brand Name: Generic only. No brands available.

Black Widow Spider (Latrodectus Mactans) Antivenin is used for:

Treating black widow spider bites.

Black Widow Spider (Latrodectus Mactans) Antivenin is an antivenin. It works by neutralizing the venom from a black widow spider bite.

Do NOT use Black Widow Spider (Latrodectus Mactans) Antivenin if:

• you are allergic to any ingredient in Black Widow Spider (Latrodectus Mactans) Antivenin

Contact your doctor or health care provider right away if any of these apply to you.

Before using Black Widow Spider (Latrodectus Mactans) Antivenin:

Some medical conditions may interact with Black Widow Spider (Latrodectus Mactans) Antivenin. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you are allergic to horse serum

Some MEDICINES MAY INTERACT with Black Widow Spider (Latrodectus Mactans) Antivenin. However, no interactions are known at this time.

This may not be a complete list of all interactions that may occur. Ask your health care provider if Black Widow Spider (Latrodectus Mactans) Antivenin may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Black Widow Spider (Latrodectus Mactans) Antivenin:

Use Black Widow Spider (Latrodectus Mactans) Antivenin as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Black Widow Spider (Latrodectus Mactans) Antivenin is usually administered as an injection at your doctor's office, hospital, or clinic.


• If Black Widow Spider (Latrodectus Mactans) Antivenin contains particles or is discolored, or if the vial is cracked or damaged in any way, do not use it.


• Black Widow Spider (Latrodectus Mactans) Antivenin should be used as soon as possible to obtain relief.


• Keep this product, as well as syringes and needles, out of the reach of children. Do not reuse needles, syringes, or other materials. Dispose of properly after use. Ask your doctor, nurse, or pharmacist to explain local regulations for proper disposal.


• If you miss a dose of Black Widow Spider (Latrodectus Mactans) Antivenin, contact your doctor right away.

Ask your health care provider any questions you may have about how to use Black Widow Spider (Latrodectus Mactans) Antivenin.

Important safety information:

• Other medicines and treatment measures, such as warm baths, will help in relieving pain.


• Black Widow Spider (Latrodectus Mactans) Antivenin is made from horse serum. Sensitivity tests may be required if you have ever had an allergic reaction to products from horses.


• LAB TESTS may be performed to monitor your progress or to check for side effects. Be sure to keep all doctor and lab appointments.


• PREGNANCY and BREAST-FEEDING: If you are pregnant, discuss with your doctor the benefits and risks of using Black Widow Spider (Latrodectus Mactans) Antivenin during pregnancy. It is unknown if Black Widow Spider (Latrodectus Mactans) Antivenin is excreted in breast milk. If you are or will be breast-feeding while you are using Black Widow Spider (Latrodectus Mactans) Antivenin, check with your doctor or pharmacist to discuss the risks to your baby.

Possible side effects of Black Widow Spider (Latrodectus Mactans) Antivenin:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Pain or discomfort near the injection site.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing or swallowing; tightness in the chest; swelling of the mouth, face, lips, or tongue) or delayed allergic reactions 1 to 2 weeks after receiving Black Widow Spider (Latrodectus Mactans) Antivenin; fever; joint and muscle pain; swollen lymph glands.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.

Proper storage of Black Widow Spider (Latrodectus Mactans) Antivenin:

Store Black Widow Spider (Latrodectus Mactans) Antivenin in a refrigerator between 36 and 46 degrees F (2 and 8 degrees C). Do not freeze. Keep Black Widow Spider (Latrodectus Mactans) Antivenin out of the reach of children and away from pets.

General information:

• If you have any questions about Black Widow Spider (Latrodectus Mactans) Antivenin, please talk with your doctor, pharmacist, or other health care provider.


• Black Widow Spider (Latrodectus Mactans) Antivenin is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Black Widow Spider (Latrodectus Mactans) Antivenin. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Black Widow Spider (Latrodectus Mactans) Antivenin resources

• Black Widow Spider (Latrodectus Mactans) Antivenin Use in Pregnancy & Breastfeeding
• Black Widow Spider (Latrodectus Mactans) Antivenin Drug Interactions
• Black Widow Spider (Latrodectus Mactans) Antivenin Support Group
• 0 Reviews for Black Widow Spider (Latrodectus Mactans) Antivenin - Add your own review/rating

Compare Black Widow Spider (Latrodectus Mactans) Antivenin with other medications

• Venomous Spider Bite

Fentanilo Sanderson

Fentanilo Sanderson may be available in the countries listed below.

Ingredient matches for Fentanilo Sanderson

Fentanyl

Fentanyl is reported as an ingredient of Fentanilo Sanderson in the following countries:

• Peru

International Drug Name Search

Duodote

In the US, Duodote (atropine/pralidoxime systemic) is a member of the drug class antidotes and is used to treat Nerve Agent Poisoning and Organophosphate Poisoning.

US matches:

• DuoDote

Ingredient matches for Duodote

Atropine

Atropine sulfate (a derivative of Atropine) is reported as an ingredient of Duodote in the following countries:

• United States

Pralidoxime

Pralidoxime chloride (a derivative of Pralidoxime) is reported as an ingredient of Duodote in the following countries:

• United States

International Drug Name Search

Capto comp.-CT

Capto comp.-CT may be available in the countries listed below.

Ingredient matches for Capto comp.-CT

Captopril

Captopril is reported as an ingredient of Capto comp.-CT in the following countries:

• Germany

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Capto comp.-CT in the following countries:

• Germany

International Drug Name Search

Family Dog and Cat

Family Dog and Cat may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Family Dog and Cat

Tetramethrin

Tetramethrin is reported as an ingredient of Family Dog and Cat in the following countries:

• Portugal

International Drug Name Search

Glukamin

Glukamin may be available in the countries listed below.

Ingredient matches for Glukamin

Amikacin

Amikacin sulfate (a derivative of Amikacin) is reported as an ingredient of Glukamin in the following countries:

• Ecuador

International Drug Name Search

Estrofem

In the US, Estrofem is a member of the drug class estrogens and is used to treat Atrophic Urethritis, Atrophic Vaginitis, Breast Cancer - Palliative, Hypoestrogenism, Oophorectomy, Osteoporosis, Postmenopausal Symptoms, Primary Ovarian Failure and Prostate Cancer.

Ingredient matches for Estrofem

Estradiol

Estradiol is reported as an ingredient of Estrofem in the following countries:

• Argentina


• Bosnia & Herzegowina


• Denmark


• Estonia


• Greece


• Ireland


• Israel


• Latvia


• Lithuania


• Luxembourg


• New Zealand


• Poland


• Romania


• Russian Federation


• Serbia


• Singapore


• Slovenia


• South Africa

Estradiol hemihydrate (a derivative of Estradiol) is reported as an ingredient of Estrofem in the following countries:

• Australia


• Austria


• Bahrain


• Belgium


• Bulgaria


• Croatia (Hrvatska)


• Cyprus


• Czech Republic


• Egypt


• Finland


• France


• Ghana


• Hong Kong


• Hungary


• Iceland


• Iran


• Iraq


• Italy


• Jordan


• Kenya


• Kuwait


• Lebanon


• Malta


• Netherlands


• Nigeria


• Oman


• Portugal


• Qatar


• Saudi Arabia


• Slovakia


• South Africa


• Sri Lanka


• Sudan


• Switzerland


• Syria


• Tanzania


• Turkey


• Uganda


• Yemen


• Zambia

International Drug Name Search

Prazolin

Prazolin may be available in the countries listed below.

Ingredient matches for Prazolin

Omeprazole

Omeprazole is reported as an ingredient of Prazolin in the following countries:

• Greece

International Drug Name Search

Cefazolin Hexal

Cefazolin Hexal may be available in the countries listed below.

Ingredient matches for Cefazolin Hexal

Cefazolin

Cefazolin sodium salt (a derivative of Cefazolin) is reported as an ingredient of Cefazolin Hexal in the following countries:

• Germany

International Drug Name Search

Eparina Calcica ratiopharm

Eparina Calcica ratiopharm may be available in the countries listed below.

Ingredient matches for Eparina Calcica ratiopharm

Heparin

Heparin calcium salt (a derivative of Heparin) is reported as an ingredient of Eparina Calcica ratiopharm in the following countries:

• Italy

International Drug Name Search

Emetrol

In the US, Emetrol (phosphorated carbohydrate solution systemic) is a member of the drug class miscellaneous antiemetics and is used to treat Nausea/Vomiting.

US matches:

• Emetrol Solution

Ingredient matches for Emetrol

Domperidone

Domperidone is reported as an ingredient of Emetrol in the following countries:

• Taiwan

International Drug Name Search

Meto APS

Meto APS may be available in the countries listed below.

Ingredient matches for Meto APS

Metoprolol

Metoprolol tartrate (a derivative of Metoprolol) is reported as an ingredient of Meto APS in the following countries:

• Germany

International Drug Name Search

Amoxicilline A

Amoxicilline A may be available in the countries listed below.

Ingredient matches for Amoxicilline A

Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxicilline A in the following countries:

• Netherlands

International Drug Name Search

A-Card

A-Card may be available in the countries listed below.

Ingredient matches for A-Card

Isosorbide Mononitrate

Isosorbide Mononitrate is reported as an ingredient of A-Card in the following countries:

• Bangladesh

International Drug Name Search

Folsäure Heumann

Folsäure Heumann may be available in the countries listed below.

Ingredient matches for Folsäure Heumann

Folic Acid

Folic Acid is reported as an ingredient of Folsäure Heumann in the following countries:

• Germany

International Drug Name Search

Morfine HCl A

Morfine HCl A may be available in the countries listed below.

Ingredient matches for Morfine HCl A

Morphine

Morphine hydrochloride (a derivative of Morphine) is reported as an ingredient of Morfine HCl A in the following countries:

• Netherlands

International Drug Name Search

Carbomedac

Carbomedac may be available in the countries listed below.

Ingredient matches for Carbomedac

Carboplatin

Carboplatin is reported as an ingredient of Carbomedac in the following countries:

• Finland


• Germany

International Drug Name Search

Captopril Hydrochlorothiazide Stada

Captopril Hydrochlorothiazide Stada may be available in the countries listed below.

Ingredient matches for Captopril Hydrochlorothiazide Stada

Captopril

Captopril is reported as an ingredient of Captopril Hydrochlorothiazide Stada in the following countries:

• Spain

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Captopril Hydrochlorothiazide Stada in the following countries:

• Spain

International Drug Name Search

Tussigon

In the US, Tussigon (homatropine/hydrocodone systemic) is a member of the drug class upper respiratory combinations and is used to treat Cough.

US matches:

• Tussigon

Ingredient matches for Tussigon

Homatropine

Homatropine Methylbromide is reported as an ingredient of Tussigon in the following countries:

• United States

Hydrocodone

Hydrocodone tartrate (a derivative of Hydrocodone) is reported as an ingredient of Tussigon in the following countries:

• United States

International Drug Name Search